Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: David Graham who wrote (6749)	2/12/2001 7:43:24 PM
From: Joe Krupa	Respond to of 14101

Hi David, "? I don't know much about this company, but from what I can tell, they have a larger market cap and they haven't even filed for FDA approval yet. Nobody ever said the world was fair -- let alone the stock market. The valuation differences between Dimethaid and Hemosol have always been a peeve of mine -- $326 million for Dimethaid, and $594 million for HML. You are right, Hemosol has not even filed for FDA approval for Hemolink yet. Heck, they have not even completed their phase III trials for US and Europe yet. Furthermore, the market for blood substitutes is about $750 million, while around $6 billion for OA drugs. And quite frankly, Dimethaid has a much more exciting product pipeline than Hemosol. Aaaarrrrggggghhhh!!!!

To: David Graham who wrote (6749)	2/13/2001 4:32:52 PM
From: Cal Gary	Read Replies (2) \| Respond to of 14101

Hi David, what do you know of house 135 State Street? They bought just under 40,000 shares today. TD bought a 25,000 bunch around noon hour as well. Gotta think that's non-retail. Thanks David. Is it: (A) ssga.com State Street Global Advisor As the sixth largest money manager in the world, SSgA provides investment strategies and integrated solutions from 30 offices around the globe. (B) maxxinvest.com State Street Brokerage is a division of State Street Capital Markets, LLC (SSCM). SSCM is a wholly owned subsidiary of State Street Corporation. SSCM is a member of the National Association of Securities Dealers, Inc. (NASD), the Securities Investor Protection Corporation (SIPC) and the Boston Stock Exchange (BSE). Mutual Funds and other securities made available through State Street Brokerage are not bank deposits, are not FDIC-insured and are not obligations of, or guaranteed by State Street Bank, or any of its affiliates, and involve investment risks, including the possible loss of the principal. For more information and a fund prospectus, you may call State Street Brokerage at 1-800-892-4514. (C) biz.yahoo.com Expands State Street's Presence in High Net Worth Market Partnership of Recognized Leaders in Institutional Investment Management and Wealth Management Creates Strong Platform for Growth in Private Asset Management BOSTON--(BUSINESS WIRE)--Dec. 7, 2000-- State Street Corporation (NYSE:STT - news) announced today it has signed a definitive agreement to purchase a majority interest in Bel Air Investment Advisors LLC, a Los Angeles-based independent investment management firm. State Street Global Advisors (SSgA), the investment management group of State Street, will significantly enhance its position as a premier provider of wealth management services to the ultra high net worth individual through this transaction